摘要 |
Suspensions containing tylosine (I) or a salt of (I), hydrocortisone acetate (II), 5-chloro-7-iodo-8-hydroxyquinoline (III), and ethinyloestradiol (IV) are new. - Suspensions contg. 1.5-3% (I); 0.003-0.01% (II); 2.5-5% (III); and 0.002-0.003% (IV) are pref. esp. those in which the suspension contains a carboxy vinyl polymer, a polyethylene glycol sorbitan fatty acid ester and a sodium citrate-citric acid buffer.
|